New heart pump aims to make risky artery procedures safer
NCT ID NCT04477603
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a temporary heart pump called Impella ECP in 100 adults undergoing high-risk angioplasty. The pump helps maintain blood flow during the procedure. Researchers are checking if the device is safe and works as intended, with follow-up for 30 days after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Impella ECP (a temporary heart pump device)
What this could lead to
If successful, this device could provide safer hemodynamic support during high-risk angioplasty, potentially reducing complications.
What could go wrong
This is an early feasibility study with only 100 participants, so results may not apply broadly. The device carries risks like bleeding or vessel damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henry Ford Health St. John Hospital
Detroit, Michigan, 48236, United States
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
The Christ Hospital
Cincinnati, Ohio, 45219, United States
-
The Valley Hospital
Paramus, New Jersey, 07652, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States